Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers

Class:IdLiteratureReference:9701740
_displayNameMechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers
_timestamp2020-09-28 00:17:08
author[Person:6806119] Katayama, Ryohei
[Person:9700355] Shaw, Alice T
[Person:9700379] Khan, Tahsin M
[Person:9701738] Mino-Kenudson, Mari
[Person:9701743] Solomon, Benjamin J
[Person:8853462] Halmos, Balazs
[Person:9701742] Jessop, Nicholas A
[Person:9701747] Wain, John C
[Person:9701745] Yeo, Alan Tien
[Person:2460005] Benes, Cyril
[Person:6798848] Drew, Lisa
[Person:9701739] Saeh, Jamal Carlos
[Person:9701741] Crosby, Katherine
[Person:9701746] Sequist, Lecia V
[Person:5250764] Iafrate, A John
[Person:9029753] Engelman, Jeffrey A
created[InstanceEdit:9701744] Rothfels, Karen, 2020-09-28
journalSci Transl Med
pages120ra17
pubMedIdentifier22277784
titleMechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers
volume4
year2012
(literatureReference)[FailedReaction:9715357] crizotinib-resistant ALK mutants don't bind crizotinib [Homo sapiens]
[DefinedSet:9700564] crizotinib resistant ALK mutants [plasma membrane] [Homo sapiens]
[EntityWithAccessionedSequence:9701818] ALK T1151dup [plasma membrane] [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers (9701740)